Imbria Pharmaceuticals Funding: $144M Raised, Series B

Imbria Pharmaceuticals funding overview

Imbria Pharmaceuticals is a Biotech company based in Boston, Massachusetts. Imbria Pharmaceuticals has raised $144M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2025. The round record for Imbria Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include Deep Track Capital, AN Ventures, Catalio Capital Management, Cytokinetics, RA Capital Management, SV Health Investors. 6 distinct backers are named across the disclosed rounds.

Imbria Pharmaceuticals at a glance

Total raised: $144M
Latest round: Series B
Latest round date: April 2025
Industry: Biotech
Headquarters: Boston, Massachusetts
Notable investors: Deep Track Capital, AN Ventures, Catalio Capital Management, Cytokinetics, RA Capital Management, SV Health Investors

Frequently asked about Imbria Pharmaceuticals funding

How much has Imbria Pharmaceuticals raised?: Imbria Pharmaceuticals has raised $144M in total disclosed funding across the rounds on record.
Who has invested in Imbria Pharmaceuticals?: Deep Track Capital, AN Ventures, Catalio Capital Management, Cytokinetics, RA Capital Management, SV Health Investors are named among the investors backing Imbria Pharmaceuticals.
What was the latest Imbria Pharmaceuticals funding round?: The most recent disclosed round is a Series B, announced in April 2025.
Where is Imbria Pharmaceuticals based?: Imbria Pharmaceuticals is based in Boston, Massachusetts.
What sector does Imbria Pharmaceuticals operate in?: Imbria Pharmaceuticals is tracked under Biotech from Boston, Massachusetts, with $144M in disclosed funding.
When did Imbria Pharmaceuticals last raise?: The last disclosed Imbria Pharmaceuticals round closed in April 2025 at Series B.

Every Imbria Pharmaceuticals figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Boston at a similar stage.

Imbria Pharmaceuticals Funding: $144M Raised, Series B

Imbria Pharmaceuticals funding overview

Imbria Pharmaceuticals at a glance

Frequently asked about Imbria Pharmaceuticals funding

Companies related to Imbria Pharmaceuticals (40)

Browse related funding lists (9)